HIV Molecular Immunology Database
Databases
Sequence DB
Immunology DB
Neutralization DB
Ab contacts DB
HCV Databases
HFV Databases
Search
CTL/CD8+ Search
T Helper/CD4+ Search
Antibody Search
CTL Variant Search
T Helper Variant Search
Patient Search
JSON API Information
Search Help
Old Search
Tools
All Immunology Tools
CATNAP
CombiNAber
HIV Genome Browser
Quickalign
CAByN
Analyze Align
Alignment Slicer
PeptGen
PepMap
Motif Scan
Hepitope
HLA Freq Analysis
ELF
Sequence Locator
SeqPublish
Heatmap
Epigraph Vaccine Suite
Mosaic Vaccine Suite
N-Glycosite
Highlighter
Protein Feature Accent
Variable Region
Neutralization Index
Products
Epitope Maps
Epitope & Antibody Tables
Epitope Alignments
Epitope Density Plots
T-Cell Epitope Variants
Neutralizing Ab Resources
& CATNAP
Data Sets: HLA Typing and
Epitope Mapping
Tools & Links
Info
Compendia
Reviews
About the Database
FAQ
How to Cite this Database
Sequence Alignments
Database Tutorials
HIV Molecular Immunology Database Search
CTL/CD8+ Search
Search Help
How to Find Information
HIV protein
-ALL-
Gag
p17
p24
p2p7p1p6
Gag/Pol
Pol
Gag/Pol-TF
Protease
RT
Integrase
Vif
Vpr
Tat
Rev
Vpu
Env
Nef
Cryptic
Antisense protein (ASP)
HIV-1
HIV-2 proteins
SIV proteins
HXB2 protein location
–
Results overlap with query location
Results contained within query location
Results exactly match query location
HXB2 DNA location
–
Results overlap with query location
Epitope
Results contain query sequence
Results exactly match query sequence
Results fuzzy match to query sequence
Epitope name
Record number
Subtype
-ALL-
A
A1
A3
AG
B
BC
C
CRF01_AE
CRF02_AG
CRF06_cpx
CRF09_cpx
D
F
F1
G
H
HIV-2
J
K
M group
multiple
U
Immunogen
-ALL-
engineered
HIV-1 and HCV co-infection
HIV-1 exposed seronegative
HIV-1 infected monocyte-derived
HIV-1 infection
HIV-1 or HIV-2 infection
HIV-2 infection
in vitro stimulation or selection
peptide-HLA interaction
SHIV infection
SIV infection
vaccine
virus
Vaccine details
if Immunogen is Vaccine
Vaccine type
-ALL-
adeno-associated virus (AAV)
adenovirus
adenovirus type 5 (Ad5)
AIDSVAX B/E
alphavirus replicon
ALVAC-HIV
attenuated poxvirus vector NYVAC
B. abortus complex
Bacillus BCG prime with vaccinia Ankara (MVA) boost
bacteriophage coat protein
canarypox
canarypox prime with gp120 boost
canarypox prime with gp160 boost
canarypox prime with pseudovirion boost
canarypox prime with recombinant protein boost
coxsackievirus
dihydrolipoyl acetyltransferase E2 protein, of Bacillus stearothermophilus
DNA
DNA prime with Ad5 boost
DNA prime with gp120 boost
DNA prime with gp160 boost
DNA prime with modified vaccinia Ankara (MVA) boost
DNA prime with peptide boost
DNA prime with poxvirus boost
DNA prime with protein boost
DNA prime with vaccinia boost
DNA prime with virus-like particle (VLP) boost
DNA with CMV promotor
DNA with CMV promotor with cationic liposome
DNA with protein boost
fowlpox prime with modified vaccinia Ankara (MVA) boost
fowlpoxvirus
fusion protein with anthrax delivery domain
gp120 depleted whole killed virus
hemagglutinating virus of Japan (HVJ)-liposome
hepatitis B surface antigen lipoprotein particles (HsBAg)
herpes simplex virus type-1 (HSV-1) amplicon
HIV-1 immunogen
HIV-1 peptide in filamentous bacteriophage major coat protein
HIVconsv
influenza
influenza prime with vaccinia boost
ISCOM
lipopeptide
liposome
Listeria monocytogenes
Long Peptides
measles virus (MV)
Mengo virus
modified vaccinia Ankara (MVA)
nanoparticle
non-replicating adenovirus
other
peptide
peptide in liposome
PLG microparticle
polyepitope
poxvirus
protein
rabies virus
recombinant protein
Salmonella
Semliki-Forest Virus
Semliki-Forest Virus with virus-like particle boost
Sendai virus vector system (SeV)
Sindbis
vaccinia
vaccinia prime DNA boost
vaccinia prime with gp120 boost
vaccinia prime with gp160 boost
vaccinia with H1 influenza HA gene cassette
vesicular stomatitis virus (VSV)
virus
virus-like particle (VLP)
Vaccine strain
-ALL-
A clade
A clade 92RW020
A clade 92UG037.8
A clade consensus
A clade UG5.94UG018
AG recombinant HZ321
B clade
B clade 89.6
B clade 89.6P
B clade 9US715.6
B clade ADA
B clade ARV-2
B clade BH10
B clade BRU
B clade BRVA
B clade CAM-1
B clade consensus
B clade HXB2
B clade HXB3
B clade HXBc2
B clade IIIB
B clade JRFL
B clade JY1
B clade LAI
B clade LR150
B clade MN
B clade NL43
B clade pNL423-ZF1
B clade RF
B clade SC
B clade SF162
B clade SF2
B clade SIMI
B clade W61D
C clade
C clade 96ZM651
C clade 97CN54
C clade 97ZA012
C clade C-96BW04.09
C clade C-96BW15C05
C clade consensus
C clade Du151
C clade Du422
CRF01_AE clade
CRF02 IC0928
CRF12 ARMA159
D clade
D clade NDK
E clade 93TH976.17
HIV-2 VLP
M group consensus
multiple epitope immunogen
natural variants
other
SIV
Vaccine component
-ALL-
anchored gp120
CD4bs
complete genome
Env
EnvΔV2
Env V3
Gag
Gag-Nef fusion
Gag-Pol
gp120
gp120 depleted virus
gp140
gp140ΔCFI
gp140ΔV2
gp140ΔV3
gp160
gp160 deletions
gp160ΔV3
gp41
HIV-1
HPG30
Int
mimotopes
Nef
Nef-Tat fusion
oligomeric gp140
other
p17 Gag
p17/p24 Gag
p18 Gag
p24 Gag
Pol
Protease
Rev
RT
Tat
Vif
virus
Vpr
Vpu
Adjuvant
-ALL-
aluminum hydroxide (alum)
aluminum phosphate
B7
bacterial polysaccharide
B. anthracia lethal toxin LF component
beta-glucan lentinan
block copolymer CRL8623
Bupivacaine
CAF01
cationic block copolymer K2
cationic liposome
CD40
CD80
CD86
Cholera toxin (CT)
Complete Freund's Adjuvant (CFA)
concavalin A-immobilized polystyrene nanospheres
CpG immunostimulatory sequence (ISS)
DDA
DOTAP
E. coli heat labile enterotoxin
E. coli mutant heat labile enterotoxin (LT-R72)
Flex, a dendric cell growth factor
FLt3 ligand (FL)
GM-CSF
gp41 N-HR and C-HR helical peptides
HSP70
ICAM
IFNγ
IL-12
IL-15
IL-18
IL-1α
IL-2
IL-2/Ig
IL-4
Immune stimulating complexes (ISCOM)
Incomplete Freund's Adjuvant (IFA)
in vivo electroporation
LFA-3
lipopolysaccharide (LPS)
liposome
LTK63
macrophage activating lipopeptide (MALP)
MF59
MIP-1α
Montanide (ISA 51)
Montanide (ISA 720)
oligomannose
Other
P30
PLG
poly(I:C)
QS21
red blood cells
reovirus alpha 1 protein
Ribi adjuvant (MPL+TDM) (RIBI)
urea
vesicular stomatitis virus glycoprotein (VSV-G)
Species
-ALL-
baboon
chimpanzee
guinea pig
human
humanized mouse
humanized rabbit
macaque
mouse
rabbit
scid-hu mouse
transgenic mouse
Restricting MHC/HLA
-ALL-
A*01
A*01:01
A*01:23
A*02
A*02:01
A*02:02
A*02:05
A*02:06
A*02:07
A*02:14
A*02:17
A*03
A*03:01
A03 supertype
A1
A*11
A11
A*11:01
A*11:03
A11.1
A19
A2
A*23
A23
A*23:01
A*24
A24
A*24:02
A*25
A25
A*25:01
A*26
A26
A*26:01
A*26:02
A*26:03
A*26:38
A28
A28 supertype
A*29
A29
A*29:02
A2 supertype
A3
A*30
A30
A*30:01
A*30:02
A*31
A31
A*31:01
A*32
A32
A*32:01
A*33
A33
A*33:01
A*33:03
A*34
A*34:02
A*36
A3 supertype
A*43:01
A*66
A*68
A68
A*68:01
A*68:02
A68 supertype
A*69
A*74
A74
A*74:01
A*80
A*80:01
B*07
B*07:02
B*07:05
B*08
B*08:01
B12
B*13
B13
B*13:02
B*14
B14
B*14:01
B*14:02
B*14:03
B*15
B15
B*15:01
B*15:02
B*15:03
B*15:10
B*15:16
B*15:17
B*15:24
B*15:40
B17
B*18
B18
B*18:01
B*27
B27
B*27:02
B*27:03
B*27:05
B*35
B35
B*35:01
B*35:02
B*35:03
B*35:05
B*35:08
B*37
B37
B*37:01
B*38
B38
B*38:01
B*39
B39
B*39:01
B*39:10
B*40
B40
B*40:01
B*40:02
B*40:06
B*41
B*42
B42
B*42:01
B*42:02
B*44
B44
B*44:02
B*44:03
B*44:15
B44 supertype
B*45
B45
B*45:01
B*48:01
B*49
B49
B*49:01
B*50
B50
B*50:01
B*51
B51
B*51:01
B*52
B52
B*52:01
B*53
B53
B*53:01
B*54
B*54:01
B*55
B55
B*55:01
B56
B*57
B57
B*57:01
B*57:02
B*57:03
B*58
B58
B*58:01
B*58:02
B*60
B60
B*61
B61
B*62
B62
B*63
B63
B*67:01
B*68
B7
B*70
B70
B71
B*73
B*73:01
B*78
B7 supertype
B8
B*81
B81
B*81:01
B*82
C*01
C*01:02
C*02
C*02:02
C*03
C*03:03
C*03:04
C*04
C*04:01
C*04:07
C*05
C*05:01
C*06
C*06:02
C*07
C*07:01
C*07:02
C*07:04
C*08
C*08:01
C*08:02
C*08:04
C*12
C*12:02
C*12:03
C*14
C*14:02
C*14:03
C*15
C*15:05
C*16
C*17
C*17:01
C*18
C*18:01
Cw1
Cw2
Cw3
Cw4
Cw5
Cw6
Cw7
Cw8
DPw4.2
DR1
DR4
DRA
E*01:01
E*01:03
H-2d
H-2D
H-2Db
H2-Dd
H-2Dd
H-2Dp
H-2Dq
H-2Kd
H-2Kk
H-2Ld
H-2a
H-2b
H-2bxd
H-2d17
H-2d
H-2f
H-2kd
H-2k
H-2p
H-2q
H-2u
Mamu A*01
Mamu-A*01
Mamu-A1*002:01
Mamu-A1*043:01
Mamu A1*065:01
Mamu-A*11
Mamu-A2*05:01
Mamu A*90120-5
Mamu-B*008:01
Mamu-B*03
Mamu-B*04
Mamu B*08
Mamu B*17
Mamu-B*17
Mane A*10
Patr-B*02
Patr-B*03
Patr-B*14
Experimental methods
and outcome measured
-ALL-
CD4 T-cell Elispot - IFNγ
CD8 T-cell Elispot granzyme B
CD8 T-cell Elispot - IFNγ
CD8 T-cell RecycleSpot - IFNγ
Chromium-release assay
CTL neutralization assay
CTL suppression of replication
Cytokine production
Cytolytic LDH release assay
Cytotoxicity assay
Degranulation, CD107a and b cell surface mobilization
Delayed-type hypersensitivity (DTH)
Flow cytometric T-cell cytokine assay
FluoroSpot
Gene expression assay/analyses
Growth competition assay
HLA binding
HLA stabilization assay
Intracellular cytokine staining
In vitro proteasome digestion
IVAG challenge
Other
Pentamer labeling
Peptide titration
Proliferation
Relative replication capacity assay
Tap-binding assay
T-cell Elispot
TCR binding
Tetramer binding
Th support of CTL response
Author
First
Last
Country
-ALL-
Argentina
Australia
Barbados
Belgium
Botswana
Brazil
Burkina Faso
Cameroon
Canada
Chile
China
Cote D'Ivoire
Democratic Republic of the Congo
Denmark
Dominican Republic
Ethiopia
Finland
France
Gambia
Germany
Ghana
Guinea-Bissau
Haiti
India
Iran
Italy
Jamaica
Japan
Kenya
Korea, Republic of
Malawi
Mali
Mexico
Mozambique
Netherlands
Nigeria
Pakistan
Peru
Philippines
Puerto Rico
Rwanda
Senegal
Somalia
South Africa
Spain
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Uganda
United Kingdom
United States
Viet Nam
Zambia
Zimbabwe
Keywords
-ALL-
acute/early infection
adjuvant comparison
A-list
antagonism
antibody binding site
antibody generation
antibody lineage
assay or method development
autologous responses
binding affinity
bispecific/trispecific
broad neutralizer
CD4+ CTL
cell-line isolated antibody
characterizing CD8+ T cells
chronic infection
class I down-regulation by Nef
compensatory mutation
computational prediction
contact residues
co-receptor
cryptic epitope
dendritic cells
drug resistance
dynamics
early-expressed proteins
early treatment
effector function
elite controllers and/or long-term non-progressors
enhancing activity
epitope processing
escape
genital and mucosal immunity
germline
glycosylation
HAART, ART
HIV-2
HIV exposed persistently seronegative (HEPS)
HIV reservoir/latency/provirus
HLA associated polymorphism
HLA cross-presentation
immunodominance
immunomodulation
immunotherapy
junction or fusion peptide
kinetics
memory cells
mimotopes
mother-to-infant transmission
mutation acquisition
naive T cells
Nef-mediated down-regulation
neutralization by CTL
NK cells
non-susceptible form
novel epitope
optimal epitope
protective allele
rate of progression
regulatory T cells
responses in children
review
SIV
structure
subtype comparisons
superinfection
supertype
supervised treatment interruptions (STI)
synthetic peptide
T-cell crossreactivity to human proteins
TCR usage
Th1
Th2
therapeutic vaccine
transmission pair
vaccine antigen design
vaccine-induced immune responses
variant cross-reactivity
viral fitness and/or reversion
viral replication
Notes
Questions or comments? Contact us at
immuno@lanl.gov